Our study uncovers the RMRP-miR-206-AKT regulatory axis as a new pathway that plays a critical role in promoting the growth and migration of aggressive breast cancer cells, which could serve as a potential target pathway for future development of prognostic biomarkers or therapeutic strategies for this type of cancer. This evidence concerns the gene AKT1 and cancer.